These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1440403)

  • 1. [The extracorporeal immunopharmacotherapy of severe glucocorticoid-dependent atopic diseases].
    Kurbacheva OM; Poroshina IuA; Chitaeva VG; Leskov VP; Prozorovskiĭ NS; Fedenko ES; Gushchin IS
    Ter Arkh; 1992; 64(8):73-6. PubMed ID: 1440403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of specific immunotherapy on peripheral T-lymphocytes in atopic patients].
    Anania A; Marino G; Cascio G
    Minerva Med; 1996 Jun; 87(6):263-7. PubMed ID: 8700354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific immunotherapy stimulates the binding of histamine H2 receptor antagonist by lymphocytes.
    Zak-Nejmark T; Małolepszy J; Nadobna G; Kuczyńska-Sekieta K; Marczyńska-Sarul E; Jutel M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):113-6. PubMed ID: 1299167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunocorrective therapy of patients with a severe form of infectious-allergic bronchial asthma].
    Shmelev EI; Bumagina TK; Samokhin AV; Zamchiĭ AA; Miterev IuG
    Ter Arkh; 1983; 55(3):25-9. PubMed ID: 6857529
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical effect of extracorporeal immunosorption].
    Raudla LA; Lebedin IuS; Chuchalin AG
    Ter Arkh; 1991; 63(10):108-11. PubMed ID: 1805406
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunotherapy, clinical and bronchial response].
    Martín Muñoz MF
    Allergol Immunopathol (Madr); 1996; 24 Suppl 1():68-79. PubMed ID: 8815725
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
    Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
    Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
    Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
    Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of specific immunotherapy on the structural properties of the lymphocyte membranes in atopic diseases].
    Cherkashin SIu; Nagornaia IN; Tananko EM; Dymshits LB; Nosikova TA
    Ter Arkh; 1989; 61(7):95-7. PubMed ID: 2588151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An evaluation of the long-term effect of clustered immunotherapy in house-dust-mite-sensitive adult bronchial asthma].
    Nagata M; Tanaka K
    Arerugi; 2001 May; 50(5):435-9. PubMed ID: 11436329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pollen-induced allergy. Programming and monitoring of specific immunotherapy].
    Obtułowicz K
    Folia Med Cracov; 1988; 29(1-2):21-48. PubMed ID: 3255656
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the effectiveness of 2 methods of specific immunotherapy of pollinoses].
    Polsacheva OV; Gushchin IS; Poroshina IuA; Chitaeva VG; Shustova VI
    Ter Arkh; 1986; 58(4):120-3. PubMed ID: 2424113
    [No Abstract]   [Full Text] [Related]  

  • 14. Where do we stand: the basic treatment of asthma and atopy: are we making backward progresses?
    Panzani RC; Ariano R; Saraga J
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):262-70. PubMed ID: 16285231
    [No Abstract]   [Full Text] [Related]  

  • 15. Double sensitization to enzymes in a baker.
    Santaolalla M; De Barrio M; De Frutos C; Gandolfo M; Zubeldia J; Rubio M; Rodríguez A; Baeza ML
    Allergy; 2002 Oct; 57(10):957. PubMed ID: 12269946
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypes of asthma revisited upon the presence of atopy.
    Nieves A; Magnan A; Boniface S; Proudhon H; Lanteaume A; Romanet S; Vervloet D; Godard P;
    Respir Med; 2005 Mar; 99(3):347-54. PubMed ID: 15733511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte apoptosis--one of mechanisms of specific immunotherapy of atopic diseases].
    Poriadin GV; Salmasi ZhM; Makarkov AI
    Biull Eksp Biol Med; 1998 Apr; 125(4):434-6. PubMed ID: 9631730
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotherapy as a method of causal treatment of atopic bronchial asthma].
    Romański B
    Pol Tyg Lek; 1975 Feb; 30(5):207-10. PubMed ID: 1114118
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specific immunotherapy using the slow alpha fraction of Dermatophagoides pteronyssinus. Efficacy; tolerance].
    Sabbah A; Ascencio M; Mir F
    Allerg Immunol (Paris); 1989 Nov; 21(9):344-51. PubMed ID: 2624679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.